Stay updated on SENSITIZE: 4SC-202 + Pembrolizumab Clinical Trial

Sign up to get notified when there's something new on the SENSITIZE: 4SC-202 + Pembrolizumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SENSITIZE: 4SC-202 + Pembrolizumab Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page revision was updated from v3.5.3 to v3.5.4, indicating an update to the study record. This change reflects version control activity rather than a substantive modification to the study information.
    Difference
    0.1%
    Check dated 2026-05-15T05:50:45.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The page revision/version label has been updated from v3.5.0 to v3.5.3, indicating a minor site release rather than a change to the clinical trial record.
    Difference
    0.1%
    Check dated 2026-04-24T05:58:42.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    Napoli, Italy was updated to Naples, Italy in the locations list.
    Difference
    0.1%
    Check dated 2026-03-26T11:37:11.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0 and removed Revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-19T05:12:48.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    Revision: v3.4.3 replaces the previous v3.4.2 on the page.
    Difference
    0.1%
    Check dated 2026-03-12T02:48:06.000Z thumbnail image
  8. Check
    98 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 and removed the prior operating-status notice along with Revision: v3.4.1.
    Difference
    0.5%
    Check dated 2026-02-11T11:47:57.000Z thumbnail image

Stay in the know with updates to SENSITIZE: 4SC-202 + Pembrolizumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SENSITIZE: 4SC-202 + Pembrolizumab Clinical Trial page.